Tumours in which both ARID1A and ARID1B are mutated are reported to retain a wild-type allele of ARID1B, providing evidence that a certain level of wild-type ARID1B is essential to avoid synthetic lethality in ARID1A-mutant tumours [83]. Here, ARID1A is linked to neoplasm.